SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001193125-11-242292
Filing Date
2011-09-07
Accepted
2011-09-07 15:46:47
Documents
7
Period of Report
2011-06-30

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO FORM 10-Q d10qa.htm 10-Q/A 25297
  Complete submission text file 0001193125-11-242292.txt   6004081

Data Files

Seq Description Document Type Size
2 XBRL INSTANCE DOCUMENT svnt-20110630.xml EX-101.INS 1043906
3 XBRL TAXONOMY EXTENSION SCHEMA svnt-20110630.xsd EX-101.SCH 75815
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE svnt-20110630_cal.xml EX-101.CAL 50156
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE svnt-20110630_def.xml EX-101.DEF 175184
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE svnt-20110630_lab.xml EX-101.LAB 475063
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE svnt-20110630_pre.xml EX-101.PRE 366186
Mailing Address ONE TOWER CENTER EAST BRUNSWICK NJ 08816
Business Address ONE TOWER CENTER EAST BRUNSWICK NJ 08816 7324189300
SAVIENT PHARMACEUTICALS INC (Filer) CIK: 0000722104 (see all company filings)

IRS No.: 133033811 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 000-15313 | Film No.: 111078174
SIC: 2833 Medicinal Chemicals & Botanical Products